Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,920,711
+$2,928,910 QoQ
Shares Held
5,770
+32.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#1,480
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intesa Sanpaolo Wealth Management holds $21,301,372 across 9 Drug Manufacturers - General names. LLY ranks #1 (32.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,770 | $6,920,711 | |
| 2 | NVO |
Novo Nordisk A S
|
118,200 | $5,666,508 | |
| 3 | PFE |
Pfizer Inc
|
122,202 | $2,942,624 | |
| 4 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
8,726 | $1,102,442 | |
| 6 | AZN |
Astrazeneca PLC
|
5,340 | $1,012,570 | |
| 7 | MRK |
Merck & Co., Inc.
|
5,872 | $754,552 | |
| 8 | ABBV |
AbbVie Inc.
|
1,069 | $269,003 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,920,711 | 5,770 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $3,991,801 | 4,340 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,352,454 | 4,050 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||